Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Observational Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients With Advanced Colorectal Cancer

NCT06169202 is registered in ClinicalTrials.gov with China Medical University, China as lead sponsor.

NCT NCT06169202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06169202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Observational Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients With Advanced Colorectal Cancer
Lead sponsor
China Medical University, China
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
June 30, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

capecitabine, fruquintinib, gastrointestinal tumours, irinotecan